Ultra Pouches
TINA.org found Ultra marketing its oral Focus Pouch as an unapproved, unsubstantiated ADHD treatment, Adderall substitute, and source of instant focus and mental clarity; directing marketing to minors despite an inconspicuous warning that the product is not for children; encouraging use beyond the warning’s recommended limits; and enrolling consumers in inadequately disclosed autorenewing subscriptions that are difficult to cancel.
Timeline
2026
November 17
TINA.org sends complaint letters to the FTC and FDA, as well as New York state and city officials, urging them to take action to stop Ultra’s multifaceted deceptive advertising scheme.